Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Healthy Alaskan.
Press releases published on May 2, 2025
![Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED](/images/pressrelease-small.png)
Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED
GlobeNewswire
·
May 2, 2025
Glasgow, May 02, 2025 (GLOBE NEWSWIRE) -- Bacterial vaginosis or BV is a common scourge that affects most women at some point in their lives. It is a vaginal infection that invades the tissues of the vagina causing redness, soreness, extreme itching, …
The Best SARMS for Cutting, Muscle Growth, Strength & Recovery - User Guide to Buying SARM Stacks for Bulking Cycles, Fat Loss & Shredding - CrazyBulk
GlobeNewswire
·
May 2, 2025
New York City, May 02, 2025 (GLOBE NEWSWIRE) -- There are around 10-12 SARMs commonly used in bodybuilding, each tailored to specific goals like bulking, cutting, or boosting strength and recovery. Many bodybuilders combine SARMs into stacks to amplify …
Trial Finds Inquis Medical’s AVENTUS Thrombectomy System Safe and Effective for Patients with Pulmonary Embolism
GlobeNewswire
·
May 2, 2025
MENLO PARK, Calif. and WASHINGTON, May 02, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced results from its AVENTUS Trial evaluating the safety and efficacy of the company’s AVENTUS …
Sutter Health Study Highlights the Power and Potential of Ambient AI to Improve Clinician Well-Being
GlobeNewswire
·
May 2, 2025
Sacramento, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Researchers at Sutter Health, led by Cheryl Stults, Ph.D., found that an innovative ambient artificial intelligence platform showed promising results in easing the burden of clinical documentation for …
Prime Biome Reviews (URGENT DOCTOR REPORT) Unexpected Gut Benefits And Side Effects Reported By Real Users!
GlobeNewswire
·
May 2, 2025
ALBANY, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Gut health and skin care have always been treated as separate issues, with people relying on skincare products for clearer skin and digestive aids for bloating or discomfort. But what if the secret to radiant …
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced the …
ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
GlobeNewswire
·
May 2, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques IRVINE, …
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
GlobeNewswire
·
May 2, 2025
REYKJAVIK, Iceland, May 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
On track for six major study readouts across four programs over the next 12 months Ready to initiate pivotal studies in two developmental and epileptic encephalopathy (DEE) programs in mid-year 2025: EMERALD for broad DEEs with relutrigine and EMBRAVE3 for …
SS Innovations Announces Chief Financial Officer Transition
GlobeNewswire
·
May 2, 2025
FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire
·
May 2, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 2 May 2025 at 15.15 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
GlobeNewswire
·
May 2, 2025
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 2.5.2025 KLO 15.15 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss …
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
GlobeNewswire
·
May 2, 2025
LEIDEN, Netherlands …
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
GlobeNewswire
·
May 2, 2025
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
GlobeNewswire
·
May 2, 2025
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
GlobeNewswire
·
May 2, 2025
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
GlobeNewswire
·
May 2, 2025
VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “ …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on May 1, …